New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 2, 2014
12:16 EDTVRTX, TRIPStocks with call strike movement; TRIP VRTX
TripAdvisor (TRIP) January 125 call option implied volatility increased 2% to 39, Vertex (VRTX) January 120 call option implied volatility increased 3% to 40 according to IVolatility.
News For VRTX;TRIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 28, 2014
18:42 EDTVRTXOn The Fly: After Hours Movers
Subscribe for More Information
16:21 EDTVRTXVertex expects FY14 revenues $525M-$535M, consensus $551.82M
Subscribe for More Information
16:18 EDTVRTXVertex reports Q3 adjusted EPS (37c), consensus (62c)
Subscribe for More Information
October 27, 2014
08:02 EDTTRIPTripAdvisor should be bought before Q3 results, says Pacific Crest
Subscribe for More Information
October 22, 2014
05:37 EDTVRTXVertex approval could add 500 more patients, says Piper Jaffray
Subscribe for More Information
October 21, 2014
16:49 EDTVRTXVertex: FDA Advisory Committee recommends approval of KALYDECO
Vertex Pharmaceuticals announced that the U.S. Food and Drug Administrationís Pulmonary Allergy Drugs Advisory Committee voted 13-2 to recommend approval of KALYDECO in people with cystic fibrosis ages 6 and older who have the R117H mutation in the cystic fibrosis transmembrane regulatory gene, which is the indication being reviewed by the FDA.
15:25 EDTVRTXPanel backs approval for Vertex CF drug in R117H mutation, Bloomberg says
Subscribe for More Information
15:18 EDTVRTXPanel votes Vertex CF drug safe, works for R117H mutation, Bloomberg reports
Subscribe for More Information
10:00 EDTTRIPOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:11 EDTVRTXFDA Pulmonary-Allergy Drugs Advisory Committe to hold a meeting
Subscribe for More Information
October 20, 2014
16:05 EDTTRIPTripAdvisor initiated with an Outperform at Oppenheimer
Subscribe for More Information
October 17, 2014
10:27 EDTVRTXVertex FDA panel expected to be positive at Piper Jaffray
Subscribe for More Information
10:26 EDTVRTXFDA panel asked to consider benefit of Vertex drug in younger CF patients
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use